Clinical Trial Update: Cladribine Venetoclax in Monocytic AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of cladribine and venetoclax for monocytic acute myeloid leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Monocytic Leukemia

Drugs mentioned

• Cladribine (Leustatin) (cladribine)
• Venetoclax (Venclexta) (venetoclax)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING